Klaria Receives EU Notification of Allowance for Sumatriptan Alginate Film
Klaria Pharma received a Notice of Allowance from the European Patent Office for the second patent in its Sumatriptan Alginate Film portfolio, granting all claims in their entirety. The broadened protection in major markets like the EU and US allows the company to better prosecute infringement and deter competing products.
Key figures
- Drug name
- Sumatriptan Alginate Film
- Patent expiration year
- 2045
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.